Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PCORI Board Eyes Connection Between Health IT Meaningful Use And Comparative Effectiveness Research

This article was originally published in The Pink Sheet Daily

Executive Summary

Members at the Patient-Centered Outcomes Research Institute's inaugural meeting agree they should bring in HHS health IT office head to discuss intersection between electronic health records and CER.

You may also be interested in...



Inflammatory Bowel Drugs To Go Head-To-Head With PCORI Funding

A number of drug-related comparative effectiveness research projects are approved for PCORI-sponsored research in its second funding cycle. Health IT-related projects also get attention as the institute spends more than $88 million on 51 projects.

PCORI Should Consider Health IT In Setting Research Priorities – Board’s Weisman

As the Patient-Centered Outcomes Research Institute begins determining its national priorities and research agenda, one board of governors member, Johnson & Johnson executive Harlan Weisman, is stressing the importance of including health information technology in that process.

PCORI Should Consider Health IT In Setting Research Priorities – Board’s Weisman

As the Patient-Centered Outcomes Research Institute begins determining its national priorities and research agenda, one board of governors member, Johnson & Johnson executive Harlan Weisman, is stressing the importance of including health information technology in that process.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS071498

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel